| [1] |
Saha SK，Zhu AX，Fuchs CS，et al.Forty-Year Trends in Cholangiocarcinoma Incidence in the U．S.：Intrahepatic Disease on the Rise[J].Oncologist, 2016, 21(5)：594-599.
|
| [2] |
Ruzzenente A，Fassan M，Conci S，et al.Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling：Clinical and Prognostic Relevance in Surgically Resected Patients[J].Ann Surg Oncol, 2016, 23(5): 1699-1707.
|
| [3] |
Shao X，Cheng Z，Xu M，et al.Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors[J].Medicine (Baltimore)，2019，98(50)：e18370-18387.
|
| [4] |
Hou P，Kang Y，Luo J．Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a[J].Cancer Biol Ther，2018，19(11): 984-993.
|
| [5] |
Abbott JM，Zhou Q，Esquer H，et al.First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer[J].Mol Cancer Ther，2020, 19(8)：1598-1612.
|
| [6] |
Zhang B，Zhou BH，Xiao M，et al.KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma[J].Front Oncol，2020，10(6)：1025-1037.
|
| [7] |
Wang LJ，He CC，Sui X，et al.MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN [J].Oncotarget，2015，6(8)：5932-5946.
|
| [8] |
Jiao M，Ning S，Chen J，et al.Long non-coding RNA ZEB1-AS1 predicts a poor prognosis and promotes cancer progression through the miR-200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma[J].Int J Oncol，2020，56(6): 1455-1467.
|
| [9] |
Xin Y，He X，Zhao W，et al.LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p[J].Am J Transl Res, 2019，11(9)：6185-6195.
|
| [10] |
Liu FT，Zhu PQ，Luo HL，et al.Long noncoding RNA ANRIL：a potential novel prognostic marker in cancer: a meta-analysis[J].Minerva Med，2016，107(2): 77-83.
|
| [11] |
Angenard G，Merdrignac A，Louis C，et al.Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma[J].Dig Liver Dis，2019，51(9)：1337-1343.
|
| [12] |
Zhang W，Yuan W，Song J，et al.LncRna CPS1-IT1 Suppresses Cell Proliferation, Invasion and Metastasis in Colorectal Cancer[J].Cell Physiol Biochem, 2017，44(2)：567-580.
|
| [13] |
Xiaoguang Z，Meirong L，Jingjing Z，et al.Long Noncoding RNA CPS1-IT1 Suppresses Cell Proliferation and Metastasis in Human Lung Cancer[J]. Oncol Res，2017，25(3)：373-380.
|
| [14] |
Ma SL，Li AJ，Hu ZY，et al.Co-expression of the carbamoyl phosphate synthase 1 gene and its long non-coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma[J].Mol Med Rep，2015, 2(6)：7915-7926.
|
| [15] |
Gartel AL.FOXM1 in Cancer: Interactions and Vulnerabilities[J]. Cancer Res，2017，77(12)：3135-3139.
|
| [16] |
Thanan R，Kaewlert W，Sakonsinsiri C，et al.Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression[J].Int J Mol Sci, 2020，21(5)：1796-1808.
|
| [17] |
Shirota T，Ojima H，Hiraoka N，et al.Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma[J].Mol Cancer Ther，2015, 14(9): 1985-1993.
|
| [18] |
Liu LZ，Yang LX，Zheng BH，et al.CK7/CK19 index：A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients[J].J Surg Oncol, 2018，117(7)：1531-1539.
|
| [19] |
Yamada T，Nakanishi Y，Okamura K，et al.Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma[J].J Gastroenterol Hepatol, 2018，10(2): 1124-1139.
|
| [20] |
Yao RR，Li JH，Zhang R，et al.M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway[J].World J Surg Oncol，2018, 16(1): 9-17.
|
| [21] |
Thanee M，Loilome W，Techasen A，et al.Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis[J].Asian Pac J Cancer Prev, 2015，16(7): 3043- 3050.
|
| [22] |
Omichi K，Cloyd JM，Yamashita S，et al.Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma[J].Surgery，2017, 162(4)：752-765.
|
| [23] |
Buettner S，Spolverato G，Kimbrough CW，et al.The impact of neutrophil- to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma[J].Surgery, 2018，164(3)：411-418.
|
| [24] |
Asahi Y，Hatanaka KC，Hatanaka Y，et al.Prognostic impact of CD8+ T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma[J].Surg Today，2020，50(8)：931- 940.
|
| [25] |
Ma K，Wei X，Dong D，et al.PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma[J].Oncol Lett, 2017，14(1): 250-256.
|
| [26] |
Tsukagoshi M，Wada S，Yokobori T，et al.Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma [J].Cancer Sci，2016，107(2)：116-122.
|
| [27] |
Carnevale G，Carpino G，Cardinale V，et al.Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells[J].Sci Rep，2017，7(1)：14419-14433.
|
| [28] |
Lin G，Liu Y，Li S，et al.Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma[J].Oncotarget，2016，7(32)：50963-50971.
|
| [29] |
Yeh CN，Wang SY，Chen YY，et al.A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma[J]. Anticancer Res，2016，36(8)：4249-4258.
|
| [30] |
马炳奇，孟慧娟，张伟，等. 多种免疫炎症指标对肝内胆管癌患者根治性切除术后预后的预测价值[J].临床肝胆病杂志，2022，38 (9)：2061-2066.
|